The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy (Q33916677)

30 July 2017

1 reference

title

The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy (English)

1 reference

30 July 2017

arterial hypertension

0 references

Rhian M Touyz

5

0 references

Robert A. Hegele

46

Robert A Hegele

0 references

Sheldon W. Tobe

47

Sheldon W Tobe

1 reference

30 July 2017

31

Pavel Hamet

0 references

Brenda R. Hemmelgarn

3

Brenda R Hemmelgarn

1 reference

30 July 2017

24

Simon L Bacon

1 reference

30 July 2017

10

Michael D Hill

1 reference

30 July 2017

36

Ellen D Burgess

1 reference

30 July 2017

12

Jeff L Mahon

1 reference

30 July 2017

26

Alain Milot

1 reference

30 July 2017

4

Simon W Rabkin

1 reference

Canadian Hypertension Education Program

30 July 2017

48

Canadian Hypertension Education Program

1 reference

30 July 2017

14

Ernesto L Schiffrin

1 reference

30 July 2017

15

Marcel Ruzicka

1 reference

30 July 2017

38

Michel Vallée

1 reference

30 July 2017

1

Daniel G Hackam

1 reference

30 July 2017

7

Raj Padwal

1 reference

30 July 2017

8

Tavis S Campbell

1 reference

30 July 2017

17

Ross D Feldman

1 reference

30 July 2017

9

M Patrice Lindsay

1 reference

30 July 2017

22

Jonathan G Howlett

1 reference

30 July 2017

29

Jean-Martin Boulanger

1 reference

30 July 2017

41

Lawrence A Leiter

1 reference

30 July 2017

44

Vincent Woo

1 reference

30 July 2017

23

Luc Trudeau

1 reference

30 July 2017

25

Robert J Petrella

1 reference

30 July 2017

28

Denis Drouin

1 reference

30 July 2017

34

S George Carruthers

1 reference

30 July 2017

35

George Pylypchuk

1 reference

30 July 2017

30

Mukul Sharma

1 reference

30 July 2017

18

Marcel Lebel

1 reference

30 July 2017

45

Philip A McFarlane

1 reference

30 July 2017

33

George K Dresser

1 reference

30 July 2017

Nadia A Khan

2

1 reference

30 July 2017

Norman R C Campbell

6

1 reference

30 July 2017

Robert R Quinn

11

1 reference

30 July 2017

Robert J Herman

13

1 reference

30 July 2017

Pierre Larochelle

16

1 reference

30 July 2017

Luc Poirier

19

1 reference

30 July 2017

J Malcolm O Arnold

20

1 reference

30 July 2017

Gordon W Moe

21

1 reference

30 July 2017

James A Stone

27

1 reference

30 July 2017

George Fodor

32

1 reference

30 July 2017

Kevin D Burns

37

1 reference

30 July 2017

G V Ramesh Prasad

39

1 reference

30 July 2017

Richard E Gilbert

40

1 reference

30 July 2017

Charlotte Jones

42

1 reference

30 July 2017

Richard I Ogilvie

43

1 reference

30 July 2017

1 May 2010

1 reference

The Canadian Journal of Cardiology

30 July 2017

1 reference

30 July 2017

26

1 reference

30 July 2017

249-258

1 reference

30 July 2017

5

1 reference

Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886555

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886555

Renal and cardio-protective effects of direct renin inhibition: a systematic literature review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886555

The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886555

2009 Canadian Hypertension Education Program recommendations: the scientific summary--an annual update

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886555

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886555

Telmisartan to prevent recurrent stroke and cardiovascular events

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886555

Global burden of blood-pressure-related disease, 2001.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886555

Telmisartan, ramipril, or both in patients at high risk for vascular events

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886555

Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in Canada

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886555

Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886555

5 July 2018

Oral renin inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886555

The Canadian Hypertension Education Program--a unique Canadian initiative

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886555

Differences in need for antihypertensive drugs among those aware and unaware of their hypertensive status: a cross sectional survey

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886555

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886555

Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886555

A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886555

Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886555

Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886555

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886555

Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886555

The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20485689

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20485689

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/S0828-282X(10)70379-2

1 reference

release_423kt3rcovem5kgjxwohwdd3jm

30 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/423kt3rcovem5kgjxwohwdd3jm

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMCID

2886555

1 reference

30 July 2017

1 reference